Does IMIGLUCERASE Cause Product dose omission issue? 72 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Product dose omission issue have been filed in association with IMIGLUCERASE (Cerezyme). This represents 2.8% of all adverse event reports for IMIGLUCERASE.
72
Reports of Product dose omission issue with IMIGLUCERASE
2.8%
of all IMIGLUCERASE reports
0
Deaths
12
Hospitalizations
How Dangerous Is Product dose omission issue From IMIGLUCERASE?
Of the 72 reports, 12 (16.7%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMIGLUCERASE. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does IMIGLUCERASE Cause?
Exposure during pregnancy (152)
Pyrexia (133)
Fatigue (122)
Weight increased (118)
Malaise (103)
Weight decreased (95)
Dizziness (92)
Dyspnoea (80)
Pain (80)
Pneumonia (80)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which IMIGLUCERASE Alternatives Have Lower Product dose omission issue Risk?
IMIGLUCERASE vs IMIPENEM
IMIGLUCERASE vs IMIPRAMINE
IMIGLUCERASE vs IMIQUIMOD
IMIGLUCERASE vs IMITREX
IMIGLUCERASE vs IMMUNE GLOBULIN NOS